Israel-based Elbit has chosen Salomon Brothers of New York Cityas its financial adviser and investment banker to help plan aproposed corporate reorganization. Salomon Brothers will help Elbit managers examine the feasibilityof realigning Elbit and its
Israel-based Elbit has chosen Salomon Brothers of New York Cityas its financial adviser and investment banker to help plan aproposed corporate reorganization.
Salomon Brothers will help Elbit managers examine the feasibilityof realigning Elbit and its subsidiaries into new and independenthealthcare, defense and commercial companies. Elbit's board ofdirectors approved this examination in principle on Dec. 7 (SCAN12/27/95).
The selection of Salomon Brothers as financial adviser is oneof two interim steps toward a final reorganization plan, accordingto Dr. Thomas Spackman, president of Elscint's U.S. subsidiary.The selection of a management consultant to help guide planningis still pending, he said.
In other Elscint news, the company's shareholders have approvedthe sale of Elscint's Elscintec ultrasound subsidiary to Elbit.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.